Investing.com - Zealand Pharma ADR reported on Thursday first quarter earnings that beat analysts' forecasts and revenue that fell short of expectations.
Zealand Pharma ADR announced earnings per share of kr-0.8633 on revenue of kr8.02M. Analysts polled by Investing.com anticipated EPS of kr-0.9652 on revenue of kr12.36M.
Zealand Pharma ADR shares are down 35.52% from the beginning of the year and are trading at kr13.76 , down-from-52-week-high.They are under-performing the Nasdaq which is down 16.67% from the start of the year.
Zealand Pharma ADR shares gained 5.76% in intra-day trade after the report.
Zealand Pharma ADR follows other major Healthcare sector earnings this month
Zealand Pharma ADR's report follows an earnings beat by AstraZeneca ADR on Thursday, February 10, 2022, who reported EPS of kr0.835 on revenue of kr12.01B, compared to forecasts EPS of kr0.7697 on revenue of kr11.11B.
Medtronic had matched expectations on Tuesday, February 22, 2022 with third quarter EPS of kr1.37 on revenue of kr7.76B, compared to forecast for EPS of kr1.37 on revenue of kr7.88B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar